All Topics
Neuroscience of Psychedelics
How psychedelics reshape the brain — neuroplasticity, default mode network suppression, BDNF upregulation, and the neuro…
Clinical Research & Trials
Phase 1, 2, and 3 clinical trials for psilocybin, MDMA, ibogaine, ketamine, and DMT — methodology, endpoints, and emergi…
Psychedelic Pharmacology
Receptor binding, pharmacokinetics, drug interactions, and the molecular mechanisms of psilocybin, MDMA, ibogaine, DMT, …
Microdosing Research
Sub-perceptual dosing protocols, placebo-controlled trials, reported benefits, risks, and the science behind microdosing…
Integration & Therapeutic Frameworks
Preparation, set and setting, therapeutic models, and integration practices that determine outcomes in psychedelic-assis…
Veterans & Psychedelic Therapy
Treatment-resistant PTSD, traumatic brain injury, and moral injury in veterans — ibogaine, MDMA, and psilocybin as break…
Ceremonial Cacao & Plant Medicine
The history, pharmacology, and ceremonial use of Theobroma cacao — theobromine, anandamide, and cacao as a heart-opening…
Other Psychedelic Medicines
Ayahuasca, 5-MeO-DMT, mescaline, ketamine, and emerging compounds like oxa-noribogaine — intelligence signals beyond the…